IDiyas

For the Inventor, By the Inventor

Burlingame, CA, United States of America

Leping Li

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 143(Granted Patents)


Location History:

  • San Francisco, CA (US) (2013 - 2015)
  • Burlingame, CA (US) (2001 - 2016)

Company Filing History:

goldMedal12 out of 12 
 
Presidio Pharmaceuticals, Inc.
 patents
silverMedal10 out of 1,970 
 
Amgen Inc.
 patents
bronzeMedal4 out of 126 
 
Tularik Limited
 patents
4. 1 out of 832,680 
Other
 patents

Years Active: 2001-2016

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):
1. 9309260 - Inhibitors of hepatitis C virus (2016-04-12),
2. 9150554 - Fused ring inhibitors of hepatitis C (2015-10-06),
3. 9120779 - Inhibitors of HCV NS5A (2015-09-01),
4. 9085587 - Inhibitors of hepatitis C virus (2015-07-21),
5. 8999967 - Tricyclic fused ring inhibitors of hepatitis C (2015-04-07),
6. 8921369 - Inhibitors of HCV NS5A (2014-12-30),
7. 8877707 - Inhibitors of HCV NS5A (2014-11-04),
8. 8865756 - Inhibitors of HCV NS5A (2014-10-21),
9. 8822520 - Substituted bicyclic HCV inhibitors (2014-09-02),
10. 8785468 - Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions (2014-07-22),
11. 8709999 - Substituted bicyclic HCV inhibitors (2014-04-29),
12. 8618151 - Inhibitors of HCV NS5A (2013-12-31),
13. 8614207 - Inhibitors of hepatitis C virus (2013-12-24),
14. 8022061 - N-aryl pyrazole compounds, compositions, and methods for their use (2011-09-20),
15. 7572783 - Substituted benzofused heterocycles (2009-08-11),

Title: The Innovations of Leping Li in Hepatitis C Treatment

Introduction: Leping Li, an influential inventor based in Burlingame, CA, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 27 patents, he has focused particularly on developing innovative treatments for Hepatitis C virus (HCV) infections. His research not only showcases his expertise but also reflects his commitment to improving healthcare outcomes.

Latest Patents: Among Leping Li's notable inventions, two recent patents stand out. The first is related to a class of compounds that inhibit Hepatitis C Virus, along with compositions containing these compounds. This innovation provides methods for treating individuals infected with HCV, offering new hope for affected patients. The second patent revolves around fused ring inhibitors of Hepatitis C, presenting compounds of specific formulae, pharmaceutical compositions, and combination therapies aimed at effectively tackling the virus.

Career Highlights: Throughout his career, Leping Li has had the opportunity to work with prestigious organizations. He has contributed his expertise to companies such as Presidio Pharmaceuticals, Inc. and Amgen Inc., helping to advance their respective research initiatives. His work in these environments has been essential in facilitating key breakthroughs in the pharmaceutical industry.

Collaborations: In addition to his corporate engagements, Leping has collaborated with notable colleagues like Min Zhong and Xiaoqi Chen. These professional relationships have fostered innovation and knowledge sharing, further enhancing the impact of his contributions to Hepatitis C research.

Conclusion: Leping Li's inventive spirit and dedication to advancing medical treatments for Hepatitis C make him a valuable figure in the realm of pharmaceuticals. His 27 patents reflect a commitment to innovation that has the potential to change the lives of many individuals grappling with viral infections. The ongoing efforts and contributions of inventors like Leping Li are crucial in the continuous fight against diseases like Hepatitis C.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…